Loading market dashboard
Solventum Corporation
SOLVHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced that, in connection with its previously completed public offering of 15,000,000 shares of Class A common stock of the Company, including 7,698,410 shares being offered by affiliates of American Securities LLC (the “Selling Stockholders”) and 7,301,590 shares being offered by the Company, the underwriters have fully exercised their option to purchase an additional 2,250,000 shares of Class A common stock of the Company, including 1,154,760 shares from the Selling Stockholders and 1,095,240 from the Company at the public offering price of $36.00 per share, less underwriting discounts and commissions. The issuance and sale of the additional shares closed today.
Solventum Corporation (SOLV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- At the CLEANPOWER 2026 conference in Houston, SOLV Energy (Nasdaq: MWH) highlighted its work across a broad portfolio of utility-scale solar and storage projects in the United States, including more than 4 gigawatts (GWdc) of large-scale developments exceeding 600 megawatts (MWdc) in overall project size. These projects reflect a continued shift toward larger and more integrated energy infrastructure as demand for utility-scale power accelerates nationwide.
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced the pricing of an upsized public offering of its Class A common stock at a public offering price of $36.00 per share. The offering consists of 15,000,000 shares of Class A common stock of the Company, including 7,698,410 shares being offered by affiliates of American Securities LLC (the “Selling Stockholders”) and 7,301,590 shares being offered by the Company. In addition, the Selling Stockholders and the Company have granted the underwriters a 30-day option to purchase up to an additional 1,154,760 shares and 1,095,240 shares, respectively, of Class A common stock of the Company at the public offering price, less underwriting discounts and commissions.
EAGAN, Minn., May 27, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, Jun. 3, 2026, beginning at approximately 9:55 a.m.
SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced that it has launched a public offering of its Class A common stock. The offering consists of 14,000,000 shares of Class A common stock of the Company, including 7,185,181 shares being offered by affiliates of American Securities LLC (the “Selling Stockholders”) and 6,814,819 shares being offered by the Company. In addition, the Selling Stockholders and the Company intend to grant the underwriters a 30-day option to purchase up to an additional 1,077,778 shares and 1,022,222 shares, respectively, of Class A common stock of the Company at the public offering price, less underwriting discounts and commissions.
SOLV Energy, Inc. (MWH) Q1 2026 Earnings Call Transcript
Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SOLV Energy NASDAQ: MWH reported sharply higher first-quarter revenue and adjusted earnings, raised its full-year profit outlook and said demand for solar, storage and grid infrastructure remains strong as U.S. power needs accelerate.
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a long-term bullish trend.
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the first quarter ended March 31, 2026. Financial Summary (in $ millions except percentages) Three Months Ended March 31, 2026 2025 Revenue 677 408 Gross Profit 119 59 Gross Margin 17.6% 14.5% Net Loss 1 (27) (1) Adjusted Gross Profit 2 124 59 Adjusted Gross Margin 2 18.4% 14.5% Adjusted EBITDA 93 34 1) Represents Net Loss before Non-Controlling Interest 2) Adjusted Gross Profit and Adjusted Gross Margin exclude the impact of the allocation of non-cash compensation expense to cost of revenue First Quarter 2026 Financial and Recent Business Highlights Revenue of $677 million, up 66% year over year Gross Profit of $119 million, up 102% year over year Adjusted Gross Profit of $124 million, up 110% year over year Net loss of $(27) million Primarily a result of a one-time, non-cash expense of $521 million related to the modification of legacy equity awards from the reorganization in the IPO Adjusted EBITDA of $93 million, up 174% year over year Total backlog as of March 31, 2026 at $8.2 billion Nearly 22 GW under contract for O&M services Announced the acquisition of Roberson Waite Electric (“RWE”) providing the Company additional capabilities and growth opportunities in the utility services market 1) Included in total non-cash compensation expense in cost of revenue and SG&A of approx.
ST. PAUL, Minn., May 7, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, beginning at approximately 10:00 a.m.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 20-day moving average, which suggests a short-term bullish trend.
From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript
Solventum (SOLV) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.34 per share a year ago.
While the top- and bottom-line numbers for Solventum (SOLV) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for its wound care and sterilization products.
Reported sales decreased (3.0)%; organic sales increased 2.1% Affirms full-year 2026 organic sales growth and free cash flow guidance; estimates adjusted EPS will be toward the high end of existing range EAGAN, Minn., May 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2026.
SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report first quarter 2026 results on Tuesday, May 12, 2026. Management will present results during a conference call at 8:30 a.m. Eastern time.
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (Nasdaq: MWH) (“SOLV”), a leading provider of infrastructure services to the power industry, today announced it has entered into an agreement to acquire Roberson Waite Electric (“RWE”), a California-based provider of utility substation construction, testing, commissioning, and related infrastructure services.
Nelson Peltz's Trian Fund Management on Thursday called on Solventum to rightsize overhead costs, divest non-core businesses and improve capital allocation in its latest appeal for a performance turnaround at the medical device maker.
Solventum Corp (NYSE:SOLV) shares are rebounding on Thursday after activist investor Trian Fund Management released a sharply worded open letter criticizing the company's post‑spin performance and urging the board to take immediate steps to unlock shareholder value.
Solventum's Spin-Out from 3M has Maximized Executive Compensation, Not Shareholder Value Outlines Three Initiatives to Improve Performance and Drive Value Creation at Solventum NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns nearly 5% of Solventum Corporation's common stock (NYSE: SOLV) (“Solventum” or the “Company”) and is one of the Company's largest active shareholders, today published an open letter to the Solventum Board of Directors (the "Board") and an accompanying slide deck arguing that the Company continues to be significantly under-managed following its spin-out from 3M – and outlining three immediately actionable initiatives to restore performance and prioritize shareholder value creation.
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Solventum (SOLV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
B. Metzler seel. Sohn and Co. AG cut its stake in shares of Solventum Corporation (NYSE: SOLV) by 68.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,972 shares of the company's stock after selling 19,561 shares during the quarter. B.
SBC Medical Group (NASDAQ: SBC - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings. Institutional and Insider Ownership 60.8% of SBC Medical
The consensus price target hints at a 26.3% upside potential for Solventum (SOLV). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Solventum (SOLV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SOLV broke out above the 50-day moving average, suggesting a short-term bullish trend.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
SOLV Energy is undervalued, with a recurring O&M revenue stream and a robust $8B backlog supporting near-term growth. MWH's installed base and long-term O&M contracts create a higher-quality, stickier earnings profile than typical EPC contractors. Scale advantages position MWH to capture larger, more complex projects and adjacent revenue streams, widening its competitive moat.
ST. PAUL, Minn., April 14, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026, after the U.S. financial markets close.
Solventum (SOLV) is rated Very Unattractive due to negative economic earnings, low ROIC (5%), and an expensive valuation. Street Earnings and significantly overstate SOLV's true profitability; Core Earnings provide a more accurate measure. Solventum's 1Q26 Street EPS estimate is overstated by $0.78/share (58%), with Core EPS at $0.57 versus Street EPS at $1.35.
Investors looking for stocks in the Medical Services sector might want to consider either Solventum (SOLV) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks much cheaper than the value of the parts. The business could be worth about $166.6 per share based on SOTP analysis. The main idea is to keep MedSurg as the core business and see more value in the other parts on their own.
Solventum Corporation (NYSE: SOLV - Get Free Report) has earned an average recommendation of "Hold" from the thirteen brokerages that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and seven have issued a buy recommendation on the company. The
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- SOLV Energy today highlighted its industry‑leading operations and maintenance (O&M) platform, with an O&M portfolio that exceeds 20 GW of utility-scale solar and storage capacity under management as of December 31, 2025, an increase of over 2 GW from the previous year. This scale reflects SOLV Energy's growing role supporting large, complex renewable energy portfolios across the United States, with a focus on operational discipline, safety, and lifecycle performance.
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
SAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the fourth quarter and full year ended December 31, 2025. Financial Summary (in $ millions except percentages) Three Months Ended December 31, Twelve Months Ended December 31, 2025 2024 2025 2024 Revenue 794 441 2,490 1,848 Gross Profit 144 82 464 259 Gross Margin 18.1 % 18.5 % 18.6 % 14.0 % Net Income 1 36 10 149 10 Adjusted EBITDA 100 53 342 165 1) Net Income Attributable to Controlling Interest Financial and Recent Business Highlights Raised $552.5 million in net proceeds from initial public offering Repaid outstanding term loan and upsized revolver to $200 million Year-end 2025 backlog of $8 billion, an 87% increase over year-end 2024 Over 20 GW now under contract for O&M services “We closed 2025 with record financial performance that reflects the strength of our value proposition and the sustained demand for infrastructure services.
Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report fourth quarter and full year 2025 results on Thursday, March 19, 2026. Management will present results during a conference call at 8:30 a.m.
ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a virtual fireside chat at the KeyBanc Healthcare Forum on Wednesday, Mar. 18, 2026, beginning at approximately 10:30 a.m.
Shares of Solventum Corporation (NYSE: SOLV - Get Free Report) have earned an average rating of "Moderate Buy" from the twelve brokerages that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective
